List of insiders holdings for Oncorus Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| MPM BioVentures 2014 L.P. Foley Todd MPM BioVentures 2014 (B) L.P. MPM Asset Management Investors BV2014 LLC MPM BioVentures 2014 LLC MPM BioVentures 2014 GP LLC MPM ASSET MANAGEMENT LLC 10% Owner | 2020-10-21 16:05:59 | 5,296,279 0 | 5,296,279 | Form 13D |
| MPM SunStates Fund L.P. MPM Asset Management Investors SunStates Fund LLC MPM SunStates Fund GP LLC MPM SunStates GP Managing Member LLC 10% Owner | 2020-10-08 18:35:21 | 0 2,849,453 | 2,849,453 | Form 4 |
| UBS Oncology Impact Fund L.P. Oncology Impact Fund (Cayman) Management L.P. MPM Oncology Impact Management GP LLC MPM Oncology Impact Management LP 10% Owner | 2020-10-08 18:26:12 | 2,377,025 0 | 2,377,025 | Form 4 |
| GADICKE ANSBERT 10% Owner | 2020-10-08 18:28:52 | 0 2,377,025 | 2,377,025 | Form 4 |
| Flynn James E Deerfield Mgmt HIF L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Healthcare Innovations Fund L.P. Deerfield Mgmt L.P. Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. DEERFIELD PARTNERS L.P. Possible Member of 10% Group 10% Owner | 2023-01-18 19:57:58 | 1,015,154 0 | 1,015,154 | Form 13D |
| Ashburn Theodore President and CEO | 2022-03-02 16:30:22 | 211,000 0 | 211,000 | Form 4 |
| Harbin Stephen COO and Chief of Staff | 2022-11-02 16:40:14 | 150,000 0 | 150,000 | Form 4 |
| McCabe John P. CFO and Treasurer | 2022-03-02 16:40:29 | 90,000 0 | 90,000 | Form 4 |
| Goldberg John Mayer Chief Medical Officer | 2022-03-02 16:50:34 | 84,500 0 | 84,500 | Form 4 |
| Queva Christophe CSO and SVP, Research | 2022-03-02 16:45:16 | 82,500 0 | 82,500 | Form 4 |
| Shea Brian J. Interim CEO | 2023-06-16 09:20:42 | 61,085 0 | 61,085 | Form 3 |
| Wanstall Rick CFO and Treasurer | 2022-05-25 16:51:08 | 51,000 0 | 51,000 | Form 4 |
| Morrison Briggs Director | 2020-10-01 19:13:15 | 32,846 0 | 32,846 | Form 3 |
| FAMBROUGH DOUGLAS Director | 2022-06-24 06:33:45 | 25,000 0 | 25,000 | Form 4 |
| Yanni Barbara Director | 2022-06-24 06:57:39 | 12,500 0 | 12,500 | Form 4 |
| Finer Mitchell H. Director | 2022-06-24 06:37:20 | 12,500 0 | 12,500 | Form 4 |
| Nam Spencer Director | 2022-06-24 06:48:51 | 12,500 0 | 12,500 | Form 4 |
| Fenton Mary Kay Director | 2022-06-24 06:44:15 | 12,500 0 | 12,500 | Form 4 |
| Canute Scott A Director | 2022-06-24 06:39:30 | 12,500 0 | 12,500 | Form 4 |
| Rubin Eric Director | 2022-06-24 06:50:43 | 12,500 0 | 12,500 | Form 4 |
| EVNIN LUKE Director | 2022-06-24 06:42:13 | 12,500 0 | 12,500 | Form 4 |
| KIRKMAN ROBERT L Director | 2020-10-01 19:09:53 | 9,927 0 | 9,927 | Form 3 |
| Wheeler Cameron Director | 2020-10-01 19:25:41 | 0 0 | 0 | Form 3 |
| Nolte Alexander Interim CFO | 2023-05-22 17:00:27 | 0 0 | 0 | Form 3 |